Gsa Capital Partners LLP Codexis, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Codexis, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 99,629 shares of CDXS stock, worth $510,100. This represents 0.02% of its overall portfolio holdings.

Number of Shares

99,629

Previous 54,292 83.51%

Holding current value

$510,100

Previous $168,000 82.74%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$2.62 - $3.71 $118,782 - $168,200	45,337 Added 83.51%	99,629 $307,000
Q2 2024 Aug 15, 2024	BUY	$2.65 - $3.92 $12,354 - $18,275	4,662 Added 9.39%	54,292 $168,000
Q1 2024 May 03, 2024	SELL	$2.59 - $4.65 $2.04 Million - $3.66 Million	-787,406 Reduced 94.07%	49,630 $173,000
Q4 2023 Feb 16, 2024	BUY	$1.54 - $3.37 $648,304 - $1.42 Million	420,977 Added 101.18%	837,036 $2.55 Million
Q3 2023 Nov 15, 2023	BUY	$1.5 - $3.75 $624,088 - $1.56 Million	416,059 New	416,059 $786,000
Q1 2023 May 12, 2023	BUY	$3.81 - $6.76 $109,038 - $193,464	28,619 Added 21.59%	161,191 $667,000
Q4 2022 Feb 13, 2023	SELL	$4.26 - $6.84 $41,909 - $67,291	-9,838 Reduced 6.91%	132,572 $618,000
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $491,696 - $1.04 Million	81,138 Added 132.42%	142,410 $863,000
Q2 2022 Aug 09, 2022	BUY	$8.35 - $21.89 $511,621 - $1.34 Million	61,272 New	61,272 $641,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $41.78 $687,423 - $1.12 Million	-26,842 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$19.65 - $27.99 $39,103 - $55,700	-1,990 Reduced 6.9%	26,842 $624,000
Q2 2021 Aug 05, 2021	BUY	$17.48 - $25.46 $222,607 - $324,233	12,735 Added 79.11%	28,832 $653,000
Q1 2021 May 10, 2021	BUY	$18.08 - $28.8 $291,033 - $463,593	16,097 New	16,097 $368,000
Q4 2020 Feb 03, 2021	SELL	$11.7 - $23.41 $130,583 - $261,279	-11,161 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$11.21 - $13.82 $125,114 - $154,245	11,161 New	11,161 $131,000
Q1 2020 May 12, 2020	SELL	$8.78 - $18.6 $281,478 - $596,297	-32,059 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$13.12 - $17.06 $420,614 - $546,926	32,059 New	32,059 $513,000
Q3 2019 Nov 12, 2019	SELL	$12.75 - $19.01 $184,428 - $274,979	-14,465 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$17.0 - $21.88 $245,905 - $316,494	14,465 New	14,465 $267,000
Q1 2019 May 15, 2019	SELL	$15.53 - $22.15 $170,193 - $242,741	-10,959 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$14.06 - $22.57 $42,404 - $68,071	-3,016 Reduced 21.58%	10,959 $183,000
Q3 2018 Nov 13, 2018	SELL	$13.35 - $19.1 $39,062 - $55,886	-2,926 Reduced 17.31%	13,975 $240,000
Q2 2018 Aug 09, 2018	BUY	$10.35 - $16.45 $174,925 - $278,021	16,901 New	16,901 $243,000

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Codexis, Inc. Transaction History